Vijyoti Health / ROTEM® Technology

The cause of bleeding, in minutes.

Targeted and evidence based, ROTEM® identifies the cause of bleeding, significantly reducing the usage of blood, its products and components, and avoids inappropriate transfusion.

Within five-to-ten minutes, ROTEM® can determine

  • Hyperfibrinolysis
  • Platelet deficiency
  • Fibrinogen deficiency
  • Factor deficiency
  • Heparin induced bleeding

A panel approach

Allowing for enhanced decision-making in blood transfusion, ROTEM® minimizes the risks arising from RBC transfusion, including increased mortality, morbidity and hospital-acquired infection. It offers a panel approach for detecting, managing, monitoring hemostasis and preserving blood, while avoiding dangerous complications of blood transfusion.

Patient Blood Management

The benefits, in numbers.

Benefits of Patient Blood Management (PBM) and ROTEM® include the reduction of:

  • Infection rateup to 81%
  • Mortalityup to 68%
  • Hospital re-admission rateup to 43%
  • Reoperation rateup to 43%
  • Morbidityup to 41%
  • RBC transfusion10–95%
  • Hospital length of stay16–33%
  • Total hospital costs10–24%